In closing arguments on Wednesday, plaintiff's lawyer Timothy Cronin asked jurors for $6 billion in punitive damages.
Shares of Abbott Laboratories are rising and those of Reckitt Benckiser are gaining in London trading Friday, a day after a ...
Abbott stands by the vital role its preterm infant formula and human milk fortifiers serve in the hospital in nourishing ...
Mead Johnson had already been ordered to pay $60m in damages in March to Jasmine Watson, the mother whose baby died after being fed the company’s Enfamil Premature 24 brand ... pre-term infant formula ...
Harvey Jones rejected any thought of buying this former FTSE 100 darling in August but after some positive news should he now revise his opinion? The post After jumping 10% this morning is this hated ...
There are several formulas available in the market that are recommended for supplementing breast milk. Some of the most popular ones are Similac, Enfamil, Gerber, and Earth’s Best. However ...
The lawsuit alleged that Mead Johnson, which makes baby formula, had failed to warn that its products could cause the illness ...
Rob Dobson, director at S&P Global Market Intelligence, said: “UK manufacturing started the final quarter of the year on an ...
Enfamil Poly-Vi-Sol provides essential vitamins ... to use and can be given directly into the mouth or mixed with breast milk, formula, juice, cereal, or other foods to increase acceptance.
In response, shares in Reckitt Benckiser soared 9.8% to 5,144.20 pence each in London early Friday. Reckitt was the best performing stock in the FTSE 100 index which was up 0.2%. Abbott Laboratories ...
Abbott Laboratories and a unit of Reckitt Benckiser Group Plc were cleared by a jury over claims they hid risks their ...
Abbott Laboratories narrowed its full-year profit outlook, raising the midpoint slightly, as strong demand for its diabetes ...